We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Frugally Designed System to Improve Access to Fluorescence-Guided Surgery

By HospiMedica International staff writers
Posted on 14 Jan 2025

State-of-the-art technology is often used in cutting-edge surgical tools, but this can limit their overall accessibility. More...

For example, several near-infrared fluorescence-guided surgical systems have been approved for various medical uses, but they are hindered by two significant drawbacks: size and cost. These systems often have a large footprint in the operating room (OR), and some require additional assistance from another user to operate, which disrupts the surgeon's workflow. Moreover, the high price of these devices makes them unaffordable for many clinical centers, which can impact patient outcomes. To address these challenges, a research team is developing a compact fluorescence-guided surgery system made from cost-effective, off-the-shelf components, which could drastically reduce costs compared to current commercially available models.

In fluorescence-guided surgery for cancer, the first step involves administering a contrast agent that specifically targets the tumor. This agent, known as a fluorophore, emits light when exposed to certain wavelengths, allowing the surgeon to see the tumor’s boundaries and ensure the complete removal of cancerous tissue while preserving healthy tissue. It also helps detect any malignant tissue left behind during the procedure. Various fluorophores are under investigation, with some activated by visible light, making them detectable to the naked eye. However, like the glow of a firefly, the fluorescence is most visible in the dark, and turning off the lights in the operating room is not a feasible solution. To overcome this issue, researchers are exploring fluorophores that respond to near-infrared light.

Near-infrared light, which is just beyond the visible spectrum, can penetrate tissues more effectively, allowing surgeons to detect tumors deeper within the body. However, human eyes cannot see near-infrared light without a special camera that is sensitive to these wavelengths. Additionally, the signal must be projected in a way that the surgeon can view it. In existing systems, this signal is typically displayed on a nearby screen. Researchers at the University of Texas Southwestern Medical Center (Dallas, TX, USA) have been working on a low-cost, fluorescence-guided surgical system that uses goggles to view the fluorescent signal. Instead of watching the tumor’s fluorescence on a screen, this augmented reality system projects the near-infrared signal directly onto an eyepiece, allowing the surgeon to see the illuminated tumor overlaid on their field of view. Building on previous research, the team introduced their latest model, made entirely from off-the-shelf components and simple 3D-printed parts. The system consists of visible and near-infrared light sources (similar to laser pointers), a minimal camera system and processor, and commercial augmented reality glasses.

These components are connected using 3D-printed mounts, and the entire unit sits on the user's head. Along with the processor, a battery pack that powers the system is placed on the user’s waist, making the system portable and hands-free. The total cost of the individual components is around USD 1,000, and the researchers aim to make a commercial version of the system much more affordable than current models. Initially, the researchers tested the simplest camera system to see if it could detect the near-infrared signal, and to their surprise, it outperformed their earlier designs. With some adjustments, they were able to fine-tune the system to filter out background signals, providing the essential functionality for fluorescence-guided surgery.

An important advancement in their design was the placement of the cameras. Many technologies that overlay one image over another—like the fluorescence signal on the surgeon’s field of view—often suffer from the parallax effect, where the overlay is not perfectly aligned with the real image. To solve this, the team used a beamsplitter, a device that divides incoming light into two paths. The beamsplitter was placed in front of the augmented reality glasses, and the camera was positioned just above the user's eye in line with the light reflected off the beamsplitter. This setup ensures that light either passes through the beamsplitter into the eye or reflects off the beamsplitter into the camera, significantly improving the optical alignment of the system.

The team benchmarked their device against more than 10 existing fluorescence-guided systems, comparing specifications such as fluorescence sensitivity, resolution, and irradiance (brightness). Despite the smaller size and lower cost of their design, the researchers found that their goggles had comparable specifications to the more expensive systems on the market. In their study published in Nature Scientific Reports, the researchers also tested the real-world utility of their system in a mouse model, performing surgery on mice with breast tumors.

“With our system, we can see the tumors, remove them, and if there is any residual tumor left, we can see it in real time,” said senior study author Samuel Achilefu, Ph.D., professor and chair in the Department of Biomedical Engineering at UT Southwestern Medical Center. With a cost-effective approach, our team aims to make an accessible real-time fluorescence system that highlights tumors in a similar fashion across all hospitals, no matter their location or budget.”


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Glucose Meter
StatStrip®
New
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image

Explainable AI Tool Improves Brain Disorder Screening from 4D fMRI

Functional magnetic resonance imaging (fMRI) captures changes in brain activity over time, but the resulting image sequences can be difficult to analyze. Screening for brain disorders requires assessing... Read more

Critical Care

view channel
Image: Liposomes have long been used for gradual drug delivery, with their composition controlling release speed, potency, duration, and potential toxicity. (Image Credit: iStock)

New Drug Delivery System Extends Release of Local Anesthetic for Weeks

Local anesthetics used for nerve blocks often provide pain relief for only a limited period, while perioperative pain can persist much longer. Extending the duration of a nerve block therefore requires... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.